ClinicalTrials.Veeva

Menu

Assessment of Efficacy & Tolerance of Urgo 310 3166 Dressing in Local Venous or Mixed Leg Ulcers (CASSIOPEE)

U

URGO Group

Status

Completed

Conditions

Ulcers, Leg

Treatments

Device: Urgo 310 3166 dressing

Study type

Interventional

Funder types

Industry

Identifiers

NCT03126396
F-17-02-310 3166

Details and patient eligibility

About

Assessment of efficacy & tolerance of Urgo 310 3166 dressing in the treatment of local venous or mixed leg ulcers.

Full description

Assessment of efficacy, tolerance and acceptability of Urgo 310 3166 dressing in the treatment of local venous or mixed leg ulcers: multicenter trial, conducted in France.

Enrollment

51 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male or female over 18 years old who has provided his/her written informed consent
  2. Patient who can be monitored by the same investigation team throughout the whole duration of the study
  3. Patient who agrees to wear an effective venous compression system every day, associated with the trial dressing
  4. Leg ulcer with an Ankle Brachial Pressure Index (ABPI) not less than 0.7 and not more than 1.3
  5. Ulcer area between 3 and 20 cm2
  6. Ulcer duration between 3 and 18 months,
  7. Ulcer presenting a surface wound bed covered with 50% or more by granulation tissue
  8. Moderately or heavily exudative ulcers.

Exclusion criteria

A. Clinical infection on the wound bed.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

51 participants in 1 patient group

Urgo 310 3166 dressing
Experimental group
Description:
Urgo 310 3166 dressing
Treatment:
Device: Urgo 310 3166 dressing

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems